Free tool
Stocks listed on Nasdaq GM
We cover 59 companies listed on Nasdaq GM. The median market value in the group is $3.31B. Across the group, the median move over the past trading day is −0.53%. 68% of the 59 with a 200-day average trade above it. Price change over the past year runs from −41.5% to +272.0% across the middle 80 percent of the group, with a median of +36.6%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
59 of 701 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% | Nov 5, 2026 |
| AAOI | Applied Optoelectronics, Inc. Common Stock | $9.66B | Mid cap | +373.01% | Nov 5, 2026 |
| APPF | AppFolio, Inc. | $7.90B | Mid cap | −19.22% | Oct 29, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% | Nov 3, 2026 |
| CAMT | Camtek Ltd. | $6.69B | Mid cap | +64.84% | Nov 16, 2026 |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% | Nov 5, 2026 |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% | Nov 11, 2026 |
| GDS | GDS Holdings Limited | $6.52B | Mid cap | −3.30% | Nov 18, 2026 |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% | Oct 29, 2026 |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% | Nov 2, 2026 |
| TTD | The Trade Desk, Inc. | $6.12B | Mid cap | −75.25% | Nov 5, 2026 |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% | Nov 5, 2026 |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% | Nov 4, 2026 |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% | Nov 5, 2026 |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% | Nov 9, 2026 |
| ACMR | ACM Research, Inc. | $5.51B | Mid cap | +176.80% | Nov 4, 2026 |
| ENPH | Enphase Energy, Inc. | $4.92B | Mid cap | +2.28% | Oct 27, 2026 |
| DAVE | Dave Inc. | $4.75B | Mid cap | +79.15% | Nov 4, 2026 |
| RUM | RUM Group Inc. | $4.65B | Mid cap | +24.17% | Nov 9, 2026 |
| USAR | USA Rare Earth, Inc. | $4.63B | Mid cap | +20.59% | Nov 5, 2026 |
| OLLI | Ollie's Bargain Outlet Holdings, Inc. | $4.49B | Mid cap | −43.13% | Aug 27, 2026 |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% | Nov 4, 2026 |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% | Nov 5, 2026 |
| FLY | Firefly Aerospace Inc. | $3.73B | Mid cap | −52.67% | Nov 11, 2026 |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% | Nov 5, 2026 |
| FRPT | Freshpet, Inc. | $3.62B | Mid cap | +30.33% | Nov 2, 2026 |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% | Nov 3, 2026 |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% | Nov 5, 2026 |
| NMIH | NMI Holdings Inc. Class A Common Stock | $3.40B | Mid cap | +13.73% | Nov 3, 2026 |
| NVTS | Navitas Semiconductor Corporation | $3.31B | Mid cap | +108.73% | Nov 2, 2026 |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% | Nov 4, 2026 |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% | Oct 29, 2026 |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% | Nov 5, 2026 |
| SOUN | SoundHound AI, Inc. | $3.11B | Mid cap | −41.14% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% | Nov 5, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| APPN | Appian Corporation | $2.75B | Mid cap | +30.34% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% | Nov 12, 2026 |
| LUNR | Intuitive Machines, Inc. | $2.66B | Mid cap | +79.20% | Nov 10, 2026 |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% | Nov 5, 2026 |
| DJT | Trump Media & Technology Group Corp. | $2.64B | Mid cap | −46.99% | Nov 6, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% | Nov 3, 2026 |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% | Nov 12, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% | Nov 5, 2026 |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% | Nov 12, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| PAYO | Payoneer Global Inc. | $2.41B | Mid cap | +4.86% | Nov 4, 2026 |
| FIVN | Five9, Inc. | $2.39B | Mid cap | +18.47% | Nov 9, 2026 |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% | Nov 4, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% | Nov 3, 2026 |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% | Nov 5, 2026 |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% | Nov 11, 2026 |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% | Nov 9, 2026 |
| VERX | Vertex, Inc. | $2.19B | Mid cap | −46.34% | Nov 2, 2026 |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% | Nov 5, 2026 |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% | Nov 4, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% | Nov 4, 2026 |
| KEEL | Keel Infrastructure Corp. | $2.08B | Mid cap | +150.75% | Nov 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.